Target intelligence / Profile preview

Eukaryotic translation initiation factor 5 pseudogene 2 (EIF5P2)

Target: EIF5P2
Molecular classification: Other (pseudogene; related to translation initiation factor family)

Overview

Eukaryotic translation initiation factor 5 pseudogene 2 (EIF5P2) is a genetic sequence highly similar to the gene encoding eukaryotic translation initiation factor 5, but it is classified as a pseudogene. There is no evidence that it encodes a protein or participates in translation or disease pathways. Therefore, EIF5P2 is not considered a drug target, receptor, or relevant biological molecule for therapeutic development.

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 5 pseudogene 2 (EIF5P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 5 pseudogene 2 (EIF5P2).

Explore the full profile